Virus-like Particle Vaccines
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
77
NCT03867331
To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 13, 2019
Completion: May 21, 2020
NCT06736379
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Start: May 13, 2025
Completion: May 30, 2027
Loading map...